Evidence map›Paper›PMID 38668290›Full record

ArticlePathogens (Basel, Switzerland)2024

Development of a Targeted NGS Assay for the Detection of Respiratory Pathogens including SARS-CoV-2 in Felines.

Jobin J Kattoor, Mothomang Mlalazi-Oyinloye, Sarah M Nemser, Rebecca P Wilkes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. One-year surveillance ofFrontiers in veterinary science · 2025
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jobin J KattoorAnimal Disease Diagnostic Laboratory, Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA.ORCID 0000-0002-0391-0064
Mothomang Mlalazi-OyinloyeCenter for Veterinary Medicine, Vet-LIRN, Food and Drug Administration, Laurel, MD 20708, USA.
Sarah M NemserCenter for Veterinary Medicine, Vet-LIRN, Food and Drug Administration, Laurel, MD 20708, USA.
Rebecca P WilkesAnimal Disease Diagnostic Laboratory, Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA.
Center for Veterinary Medicine · USPurdue University West Lafayette · US

Funding

'COVID-19' Incorporation of SARS-CoV-2 primers into a targeted NGS panel for surveillance use in catsU18FD007495 · FDA · PURDUE UNIVERSITY · PI WILKES, REBECCA PENROSE · 2021 to 2021
$78k
FDA HHS U18 FD007495
6 · The paper itself

Abstract

Acute respiratory diseases in felines can be attributed to a diverse range of pathogens. The recent emergence of novel viruses, particularly SARS-CoV-2 and its variants, has also been associated with respiratory ailments in cats and other pets, underscoring the need for a highly sensitive diagnostic assay capable of concurrently detecting multiple respiratory pathogens. In this study, we developed a targeted next generation sequencing panel using Ion Torrent Ampliseq technology to detect multiple respiratory pathogens, including recent SARS-CoV-2 variants and Feline herpesvirus-1, Feline calicivirus,

Indexed as

Cat DiseasesCOVID-19High-Throughput Nucleotide SequencingSARS-CoV-2Sensitivity and SpecificityAnimalsBordetella bronchisepticaCalicivirus, FelineCatsChlamydiaRespiratory Tract Infectionsfeline respiratory disease panelion torrent sequencingSARS-CoV-2targeted next-generation sequencing

Identifiers

PMID38668290
PMCPMC11055025
OpenAlexW4394921676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.